Raleigh Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-154
| Closed | -$11.4K | – | 717 |
|
|
2024
Q4 | $11.4K | Buy |
154
+70
| +83% | +$5.18K | ﹤0.01% | 588 |
|
|
2024
Q3 | $5.54K | Sell |
84
-44
| -34% | -$2.9K | ﹤0.01% | 687 |
|
|
2024
Q2 | $11.8K | Buy |
128
+18
| +16% | +$1.66K | 0.01% | 540 |
|
|
2024
Q1 | $10.5K | Buy |
110
+80
| +267% | +$7.64K | ﹤0.01% | 552 |
|
|
2023
Q4 | $2.29K | Buy |
+30
| New | +$2.29K | ﹤0.01% | 851 |
|
|
2022
Q3 | – | Sell |
-44
| Closed | -$4K | – | 805 |
|
|
2022
Q2 | $4K | Hold |
44
| – | – | ﹤0.01% | 467 |
|
|
2022
Q1 | $5K | Buy |
+44
| New | +$5K | ﹤0.01% | 451 |
|